AnticoagEvaluator is a medical tool developed by the American College of Cardiology to assist clinicians in managing antithrombotic therapy for patients with non-valvular atrial fibrillation. The app provides guideline-driven therapy guidance and risk assessment based on the SPARC Tool methodology.
Overview · Full Intel report in progress
The App DNA
What makes this app unique?
For Healthcare professionals managing antithrombotic therapy for patients with non-valvular atrial fibrillation.
What does it look like?
Key features
Calculates a patient's renal function and risk levels for ischemic stroke, thromboembolism, and bleeding.
Provides ACC/AHA/HRS clinical guidance for stroke prevention strategies.
Generates therapy options based on clinical trial data tailored to specific patient characteristics.
Assists in the accurate use of direct oral anticoagulants by adjusting dosages based on renal function and patient-specific data.
How much does it cost?
Velocity
Dormant developmentShow more...
5 versions in history. Development pace: zombie.
Who built it?
American College of Cardiology
13+ apps tracked · Medical
ACC.26
CVD Risk Estimator Plus
ACC Guideline Clinical App
Lipid Manager
TreatHF
ACC Learn
Statin Intolerance
ManageAnticoag
DAPT Risk Calculator
ACC.25
ACC.24
ACC.23/WCCUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for AnticoagEvaluator
How's the Medical market?
The rivals identified
The Analyst's Read
Key takeaways for AnticoagEvaluator
Where is it heading?
Bottom line
While the app offers specialized clinical decision support, recent user feedback indicates potential technical instability regarding therapy detail navigation.
Report last updated